跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TERRYWHITE CHEMMART IBUPROFEN SODIUM Ibuprofen sodium dihydrate 256mg film coated tablet blister pack (new formulation) - TGA Drug Approval Details
Approvals
/
TGA
/
TERRYWHITE CHEMMART IBUPROFEN SODIUM Ibuprofen sodium dihydrate 256mg film coated tablet blister pack (new formulation)
Approved
STANDARD
TERRYWHITE CHEMMART IBUPROFEN SODIUM Ibuprofen sodium dihydrate 256mg film coated tablet blister pack (new formulation)
Neo Health (OTC) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
a5758072e0e6d68f
Company
Neo Health (OTC) Pty Ltd
Type
Standard
Approval Details
Approval Id
a5758072e0e6d68f
Product Name
TERRYWHITE CHEMMART IBUPROFEN SODIUM Ibuprofen sodium dihydrate 256mg film coated tablet blister pack (new formulation)
Artg Id
402305
Artg Name
TERRYWHITE CHEMMART IBUPROFEN SODIUM Ibuprofen sodium dihydrate 256mg film coated tablet blister pack (new formulation)
Sponsor
Neo Health (OTC) Pty Ltd
Company Detail Path
/organization/neo-health-otc-pty-ltd
Artg Date
2023-01-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
a5758072e0e6d68f
Type
Standard
Back to TGA Approvals